Use of AAM for Correction of Age Related Volume Deficits in the Face

Age-Related Atrophy Clinical Trial

Official title:
A Multi-Phase, Prospective, Multi-Center, Single-Blind, Clinical Study to Evaluate the Safety and Efficacy of Allograft Adipose Matrix (AAM) and Diluted AAM for Pre-Jowl and Malar Augmentation to Correct Age Related Volume Deficit in the Face

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate Allograft Adipose Matrix (AAM) in the face of people with age-related volume deficit - fat loss. AAM is a tissue used to correct fat loss. Participation in this study requires injections for placing AAM in the bilateral pre-jowl and malar areas of the face. The research will tell whether AAM is effective in maintaining mid-face fullness and whether the appearance of the skin improves after injection.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03652844
Study type	Interventional
Source	Musculoskeletal Transplant Foundation
Contact
Status	Completed
Phase	N/A
Start date	August 27, 2018
Completion date	July 12, 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03702335` - Impact of Comprehensive Dietary Counseling on Dietary Quality, Mental Health, and Quality of Life in Older Adults	N/A
Completed	`NCT03409575` - Efficacy of Neuromuscular Electrical Stimulation in Geriatric Population	N/A
Terminated	`NCT03291795` - Prehabilitation Exercise Plus Perioperative Optimization of Senior Health	N/A
Not yet recruiting	`NCT06363942` - A Personalized Video-based Exercise Program for Fall Prevention in Frail and Pre-frail Older Adult	N/A